Novel agent for papulopustular rosacea found safe, effective in phase III trials

DENVER – Ivermectin 1% cream applied once daily was effective and safe in treating patients with moderate to severe papulopustular rosacea, based on data from a pair of phase III studies.

Ivermectin...